The FDA requires generic drug manufacturers to prove bioequivalence through strict pharmacokinetic studies to ensure their products match the brand-name version in absorption and effectiveness. Learn how the 80/125 rule, biowaivers, and product-specific guidances make generics safe and affordable.
Read more